1. Introduction to the opening symposium “genetics in atherosclerosis research”

   • G. Schettler

   OriginalPaper Pages: 1 - 2

2. Application of cladistics to the analysis of genotype-phenotype relationships

   • C. F. Sing
   • M. B. Haviland
   • A. R. Templeton

   OriginalPaper Pages: 3 - 9

3. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred

   • J. Davignon
   • R. Dufour
   • S. Lussier-Cacan

   OriginalPaper Pages: 10 - 17

4. RFLPs of the LDL-receptor gene: Their use in the diagnosis of FH and in evaluation of different levels of gene expression on normal subjects

   • S. Bertolini
   • D. A. Coviello
   • S. Humphries

   OriginalPaper Pages: 18 - 25

5. Characterization of a family with moderate hypercholesterolemia and binding defective low density lipoprotein

   • A. L. Catapano
   • A. Corsini
   • R. Fumagalli

   OriginalPaper Pages: 26 - 32

6. LP(A) and the risk of coronary heart disease

   • M. Bihari-Varga
   • G. Kostner
   • A. Czinner

   OriginalPaper Pages: 33 - 35

7. Aortic features in tangier disease and pathogenetic considerations — Part I. Fatty dots and streaks

   • M. D. Haust

   OriginalPaper Pages: 36 - 47

8. Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency

   • S. Muntoni
   • B. Batetta
   • P. Pani

   OriginalPaper Pages: 48 - 53

9. Association of a polymorphism in the apo AI gene promoter with hyperalphalipoproteinemia

   • F. Pagani
   • G. A. Giudici
   • C. Vergani

   OriginalPaper Pages: 54 - 58

10. The molecular defects in lipoprotein lipase deficient patients

    • S. S. Fojo
    • O. Beg
    • H. B. Brewer Jr.

    OriginalPaper Pages: 59 - 63

11. Apo C-II deficiency type bari

    • A. Capurso
    • F. Resta
    • G. Pepe

    OriginalPaper Pages: 64 - 70

12. Factor VIII and coronary heart disease

    • F. R. Rosendaal

    Haemostatic function and cardiovascular disease Pages: 71 - 75

13. LP(A): A link between thrombosis and atherosclerosis

    • A. M. Scanu

    Haemostatic function and cardiovascular disease Pages: 76 - 78

14. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease

    • C. C. Kelleher

    Genetics in Atherosclerotic Research Pages: 79 - 82

15. Fibrinogen/fibrin in atherogenesis

    • E. B. Smith
    • W. D. Thompson
    • C. M. Stirk

    Genetics in Atherosclerosis Research Pages: 83 - 87

16. Fibrinogen and mechanisms of thrombosis. A difficult link

    • G. Di Minno
    • A. Cerbone
    • M. Mancini

    OriginalPaper Pages: 88 - 91

17. IDL, VLDL, chylomicrons and atherosclerosis

    • B. G. Nordestgaard
    • A. Tybjærg-Hansen

    OriginalPaper Pages: 92 - 98

18. The importance of triglycerides: Results from the prospective cardiovascular Münster (PROCAM) study

    • G. Assmann
    • H. Schulte

    Haeeostatic function and cardiovascular disease Pages: 99 - 103

19. Focus on anti-atherosclerotic therapy

    • F. Bernini
    • R. Paoletti

    OriginalPaper Pages: 104 - 106

20. Concept of an antiatherosclerotic efficacy of calcium entry blockers

    • S. Jost
    • W. Rafflenbeul
    • P. Lichtlen

    OriginalPaper Pages: 107 - 119

21. Activity profile of gemfibrozil on the major plasma lipoprotein parameters

    • C. R. Sirtori
    • G. Franceschini
    • L. Calabresi

    Focus on anti-atherosclerotic therapy Pages: 120 - 124

22. Atherogenic profiles in insulin-dependent diabetic patients and their treatment

    • I. De Leeuw

    Haemostatic function and cardiovascular diseases Pages: 125 - 128

23. ACE-inhibitors and atherosclerosis

    • E. Ambrosioni
    • S. Bacchelli
    • C. Borghi

    Focus on anti-atherosclerosis therapy Pages: 129 - 133

24. Insulin and atherogenesis

    • R. W. Stout

    Insulin, atherosclerosis and coronary heart disease Pages: 134 - 135

25. Insulin resistance — modelling studies

    • I. F. Godsland
    • C. Walton
    • V. Wynn

    Insuline, atherosclerosis, and coronary heart disease Pages: 136 - 138